Skip to main content
. 2019 Jan 15;12:587–598. doi: 10.2147/OTT.S187426

Figure 7.

Figure 7

Scutellarin reverses cisplatin resistance in glioma cells through regulating the ERK/p53/caspase-3 and PI3K/Akt/mTOR pathways.